One of the biggest challenges in ME/CFS research has always been the complexity of the disease. With multiple body systems likely affected — from immune function and energy metabolism to the gut microbiome and the brain — identifying reliable biological markers has remained frustratingly out of reach. But a new generation of researchers is bringing fresh tools, fresh thinking, and fresh determination to the field.
Dr Katrina Pears, MEA Research Coordinator has interviewed Aleyna Lumsden, a PhD researcher jointly based at the Rosalind Franklin Institute and the University of Oxford, whose work is pushing the boundaries of what’s possible in biomedical discovery.
Watch the interview on YouTube below
This study which has received top-up funding from the MEA Ramsay Research Fund and funding from UK Research & Innovation (UKRI) is overseen by Dr Bela Paizs, Dr Marcus Gallagher-Jones and Professor Karl Morten.
Further Information
- Using Advanced Informatics Strategies to Identify Key Disease-Associated Metabolites and Provide Evidence for Infection in ME/CFS Patients
- Research: New funding awarded to PhD project that will identify key metabolites and infection markers in ME/CFS | November 4, 2025
